Author

H. Lawrence Remmel

University Medical Center UtrechtORCID 0000-0002-5742-829XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Alex A. ZhavoronkoviD· 1 shared Alexander VeviorskiyiD· 1 shared Anastasia ShneydermaniD· 1 shared Harjinder Singh· 1 shared Khadija M. AlawiiD· 1 shared Mikhail KorzinkiniD· 1 shared Sandra S. HammeriD· 1 shared Steven C. QuayiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alex A. ZhavoronkovORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintOct 2, 2024

Comparative analysis of Endoxifen, Tamoxifen and Fulvestrant: A Bioinformatics Approach to Uncover Mechanisms of Action in Breast Cancer

H. Lawrence Remmel, Sandra S. Hammer, Harjinder Singh…·Steven C. Quay

This study compares endoxifen, tamoxifen, and fulvestrant using omics data to identify their distinct mechanisms of action in breast cancer, revealing differences in pathway effects and potential therapeutic implications.

6 citations

humanbulk RNA-seq

𝕏 PostBluesky